医学
放射治疗
危险系数
结直肠癌
累积发病率
随机对照试验
化疗
对数秩检验
癌症
内科学
外科
泌尿科
比例危险模型
置信区间
队列
作者
Samuel Y. Ngan,Bryan Burmeister,Richard Fisher,Michael J. Solomon,David Goldstein,David Joseph,Stephen P. Ackland,David Schache,Bev McClure,Sue‐Anne McLachlan,Joseph McKendrick,Trevor Leong,Cris Hartopeanu,John Zalcberg,John Mackay
标识
DOI:10.1200/jco.2012.42.9597
摘要
Three-year LR rates between SC and LC were not statistically significantly different; the CI for the difference is consistent with either no clinically important difference or differences in favor of LC. LC may be more effective in reducing LR for distal tumors. No differences in rates of distant recurrence, relapse-free survival, overall survival, or late toxicity were detected.
科研通智能强力驱动
Strongly Powered by AbleSci AI